Volume 10,Issue 1
Fall 2025
Role of Efflux Pump Gene adeIJK to Multidrug Resistance in Acinetobacter baumannii Clinical Isolates
Background: The emergence of multidrug-resistant Acinetobacter baumannii (MDRAB) as a nosocomial pathogen is one of the major public health problems. This study aimed to evaluate the role of an efflux pump gene adeJ for the multidrug resistance of A. baumannii clinical isolates. Methods: Two groups, MDRAB and susceptible A. baumannii (SAB), of A. baumannii clinical isolates were studied. The SAB group consisted of strains that did not meet the criteria of MDRAB and were susceptible to more categories of antibiotics than MDRAB. Antimicrobial susceptibility results obtained by the VITEKⅡ system were used in data analysis and bacterial group allocation. We performed real-time reverse transcription PCR to determine the relative expression of adeJ. We compared the relative expression of adeJ in comparison groups by considering two viewpoints: (1) MDRAB and SAB groups, and (2) susceptible and non-susceptible groups for each antibiotic used in this study. Results: The mean value of relative expression of adeJ of MDRAB and SAB groups was 1.4 and 0.92, respectively, and showed significant differences (P = 0.002). The mean values of relative expression of adeJ of susceptible and non-susceptible groups to the antibiotics cefepime, ceftazidime, ciprofloxacin, imipenem, meropenem, tigecycline, piperacillin/ tazobactam, ticarcillin/clavulanic acid, trimethoprim/sulfamethoxazole, piperacillin, and gentamicin showed statistically significant differences (P < 0.05). Conclusion: The overexpression of adeIJK might contribute to the multi-drug resistance in A. baumannii clinical isolates. Further, the overexpression of adeIJK might be one of the factors contributing to the resistance to numerous antibiotics.
1. Yoon EJ, Balloy V, Fiette L, et al. Contribution of the Ade Resistance-Nodulation-Cell Division-Type Efflux Pumps to Fitness and Pathogenesis of Acinetobacter baumannii. M Bio, 7: e00697-16.
2. Mera RM, Miller LA, Amrine-Madsen H, et al. Acinetobacter baumannii 2002–2008: Increase of Carbapenem-Associated Multiclass Resistance in the United States. Microb Drug Resist, 16: 209–215.
3. Hong SK, Seong MW, Lee DH, et al. Correlation between Carbapenem Prescription Trends and Imipenem Resistance in Acinetobacter baumannii at an Intensive Care Unit between 2006 and 2010. Lab Med Online, 2: 232–234.
4. Wong D, Nielsen TB, Bonomo RA, et al. Clinical and Pathophysiological Overview of Acinetobacter Infections: A Century of Challenges. Clin Microbiol Rev, 30: 409–447.
5. Coyne S, Courvalin P, Perichon B. Efflux-Mediated Antibiotic Resistance in Acinetobacter spp. Antimicrob Agents Chemother, 55: 947–953.
6. Nikaido H, Takatsuka Y. Mechanisms of RND Multidrug Efflux Pumps. Biochim Biophys Acta, 1794: 769–781.
7. Lin MF, Lin YY, Tu CC, et al. Distribution of Different Efflux Pump Genes in Clinical Isolates of Multidrug-Resistant Acinetobacter baumannii and Their Correlation with Antimicrobial Resistance. J Microbiol Immunol Infect, 50: 224–231.
8. Choi IS, Choi JA, Jang SJ, et al. Distribution of adeG, adeB, adeE, adeY, abeM, and adeJ Efflux Pump Genes in Clinical Isolates of Acinetobacter Species from Korea. Lab Med Online, 9: 201–209.
9. Yoon EJ, Chabane YN, Goussard S, et al. Contribution of Resistance-Nodulation-Cell Division Efflux Systems to Antibiotic Resistance and Biofilm Formation in Acinetobacter baumannii. M Bio, 6: e00309-15.
10. Fournier PE, Vallenet D, Barbe V, et al. Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii. PLoS Genet, 2: e7.
11. Higgins PG, Wisplinghoff H, Krut O, et al. A PCR-Based Method to Differentiate between Acinetobacter baumannii and Acinetobacter Genomic Species 13TU. Clin Microbiol Infect, 13: 1199–1201.
12. Woodford N, Ellington MJ, Coelho JM, et al. Multiplex PCR for Genes Encoding Prevalent OXA Carbapenemases in Acinetobacter spp. Int J Antimicrob Agents, 27: 351–353.
13. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-Resistant, Extensively Drug-Resistant and Pandrug-Resistant Bacteria: An International Expert Proposal for Interim Standard Definitions for Acquired Resistance. Clin Microbiol Infect, 18: 268–281.
14. Fernando D, Kumar A. Growth Phase-Dependent Expression of RND Efflux Pump- and Outer Membrane Porin-Encoding Genes in Acinetobacter baumannii ATCC 19606. J Antimicrob Chemother, 67: 569–572.
15. Rosenfeld N, Bouchier C, Courvalin P, et al. Expression of the Resistance-Nodulation Cell Division Pump AdeIJK in Acinetobacter baumannii is Regulated by AdeN, a TetR-Type Regulator. Antimicrob Agents Chemother, 56: 2504–2510.
16. Fernando DM, Xu W, Loewen PC, et al. Triclosan can Select for an AdeIJK Overexpressing Mutant of Acinetobacter baumannii ATCC 17978 that Displays Reduced Susceptibility to Multiple Antibiotics. Antimicrob Agents Chemother, 58: 6424–6231.
17. Rumbo C, Gato E, Lopez M, et al. Contribution of Efflux Pumps, Porins, and Beta-Lactamases to Multidrug Resistance in Clinical Isolates of Acinetobacter baumannii. Antimicrob Agents Chemother, 57: 5247–5257.
18. Amin IM, Richmond GE, Sen P, et al. A Method for Generating Marker-Less Gene Deletions in Multidrug-Resistant Acinetobacter baumannii. BMC Microbiol, 13: 158.
19. Jeong SH. Mechanisms of Acquiring Carbapenem-Resistance in Acinetobacter Species. Korean J Clin Microbiol, 12: 1–5.